| Issue Date | Title | Type | Author(s) |
| 2020 | Daratumumab, lenalidomide, and dexamethasone in relapsed/refractory myeloma: a cytogenetic subgroup analysis of POLLUX | Articulo | Kaufman, J.L. (Jonathan L.) ; Dimopoulos, M.A. (Meletios A.); White, D.J. (Darrell J.); Benboubker, L. (Lotfi); Cook, G. (Gordon); Leiba, M. (Merav); Morton, J. (James); Takezako, N. (Naoki); Kim, K. (Kihyun); Moreau, P. (Philippe); Sutherland, H.J. (Heather J.); Magen, H. (Hila); Iida, S. (Shinsuke); Kim, J.S. (Jin Sheok); Prince, H.M. (H. Miles); Cochrane, T. (Tara); Oriol, A. (Albert); O’Rourke, L. (Lisa); Trivedi, S. (Sonali); Casneuf, T. (Tineke); Krevvata, M. (Maria); Ukropec, J. (Jon); Kobos, R. (Rachel); Avet-Loiseau, H. (Herve); Usmani, S.Z. (Saad Z.); San-Miguel, J.F. (Jesús F.) |
| 2020 | Daratumumab plus lenalidomide and dexamethasone in relapsed/ refractory multiple myeloma: extended follow-up of POLLUX, a randomized, open-label, phase 3 study | Articulo | Bahlis, N.J. (Nizar J.); Dimopoulos, M.A. (Meletios A.); White, D.J. (Darrell J.); Benboubker, L. (Lotfi); Cook, G. (Gordon); Leiba, M. (Merav); Ho, P.J. (P. Joy); Kim, K. (Kihyun); Takezako, N. (Naoki); Moreau, P. (Philippe); Kaufman, J.L. (Jonathan L.); Krevvata, M. (Maria); Chiu, C. (Christopher); Qin, X. (Xiang); Okonkwo, L. (Linda); Trivedi, S. (Sonali); Ukropec, J. (Jon); Qi, M. (Ming); San-Miguel, J.F. (Jesús F.) |
| 2023 | Management of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN) | Revision | Terpos, E. (Evangelos); Engelhardt, M. (Monika); Delforge, M. (M.); Cook, G. (Gordon); Gay, F. (Francesca); Donk, N.W.C.J. (Niels W.C.J.) van de; Ntanasis-Stathopoulos, I. (Ioannis); Vangsted, A.J. (Annette Juul); Driessen, C. (Cristoph); Schjesvold, F.H. (Fredrik H.); Zweegman, S. (Sonja); Hajek, R. (R.); Moreau, P. (Philippe); Einsele, H. (Hermann); San-Miguel-Izquierdo, J. (Jesús Fernando); Boccadoro, M. (Mario); Dimopoulos, M.A. (Meletios A.); Sonneveld, P. (Pieter); Ludwig, H. (Heinz) |
| 2018 | Prevention and management of adverse events of novel agents in multiple myeloma: a consensus of the European Myeloma Network | Articulo | Ludwig, H. (Heinz); Delforge, M. (M.); Facon, T. (Thierry); Einsele, H. (Hermann); Gay, F. (Francesca); Moreau, P. (Philippe); Avet-Loiseau, H. (Herve); Boccadoro, M. (Mario); Hajek, R. (R.); Mohty, M. (Mohamad); Cavo, M. (Michele); Dimopoulos, M.A. (Meletios A.); San-Miguel, J.F. (Jesús F.); Terpos, E. (Evangelos); Zweegman, S. (Sonja); Garderet, L. (Laurent); Mateos, M.V. (María Victoria); Cook, G. (Gordon); Leleu, X. (Xavier); Goldschmidt, H. (Hartmut); Jackson, G.H. (Graham H.); Kaiser, M. (Martin); Weisel, K. (Katja); Donk, N.W.C.J. (Niels W.C.J.) van de; Waage, A. (Anders); Beksac, M. (Meral); Mellqvist, U. (Ulf); Engelhardt, M. (Monika); Caers, J. (Jo); Driessen, C. (Cristoph); Bladé, J. (Joan); Sonneveld, P. (Pieter) |
